Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000014

Chief Financial Officer gave up 4,929 shares (to pay taxes)

  • Chief Financial Officer acquired 42,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

WENTWORTH KORY JAMES · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-03-01 Grant or award : show line 1 in the form +42,400 116,249 D
2025-03-03 Shares withheld for taxes : show line 2 in the form −4,929 $11.68 $57,564 111,320 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-01 Grant or award : show line 3 in the form Stock Option (Right to Buy) +63,300 63,300 D
Loading xslF345X05/wk-form4_1741125633.xml…